APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Topical Acne Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Topical Acne Medication Market Outlook and Growth Opportunities 2026

Report ID 17404195042 January 2026192 pages

Choose your research edition.

Industry ResearchTopical Acne Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Acne Medication Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Topical Acne Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Acne Medication Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Acne Medication Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Topical Acne Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Topical Acne Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Topical Acne Medication market include Teva, Mylan, GlaxoSmithKline, Sun Pharma, Sine Pharma, Mayne Pharma, Lion, HUAPONT and Galderma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Topical Acne Medication market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Acne Medication and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Acne Medication revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Topical Acne Medication market.

Topical Acne Medication Segment by Company

Teva

Mylan

GlaxoSmithKline

Sun Pharma

Sine Pharma

Mayne Pharma

Lion

HUAPONT

Galderma

Bausch Health

Almirall

Topical Acne Medication Segment by Type

Prescription Medicine

Over-the-counter (OTC) Medicine

Topical Acne Medication Segment by Application

Inflammatory Acne

Non-inflammatory Acne

Topical Acne Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Topical Acne Medication status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Topical Acne Medication key companies, revenue, market share, and recent developments.

3. To split the Topical Acne Medication breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Topical Acne Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Topical Acne Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Topical Acne Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Acne Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Acne Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Acne Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Acne Medication industry.

Chapter 3: Detailed analysis of Topical Acne Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Topical Acne Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Topical Acne Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Topical Acne Medication Industry Trends Table 2. Topical Acne Medication Industry Drivers Table 3. Topical Acne Medication Industry Opportunities and Challenges Table 4. Topical Acne Medication Industry Restraints Table 5. Global Topical Acne Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Topical Acne Medication Revenue Share by Company (2021-2026) Table 7. Global Topical Acne Medication Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Topical Acne Medication Key Company Manufacturing Base & Headquarters Table 9. Global Topical Acne Medication Company, Product Type & Application Table 10. Global Topical Acne Medication Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Topical Acne Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prescription Medicine Table 15. Significant Companies of Over-the-counter (OTC) Medicine Table 16. Global Topical Acne Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Topical Acne Medication Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Topical Acne Medication Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Topical Acne Medication Sales Value Share by Type (2021-2026) Table 20. Global Topical Acne Medication Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Inflammatory Acne Table 22. Significant Companies of Non-inflammatory Acne Table 23. Global Topical Acne Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Topical Acne Medication Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Topical Acne Medication Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Topical Acne Medication Sales Value Share by Application (2021-2026) Table 27. Global Topical Acne Medication Sales Value Share by Application (2027-2032) Table 28. Global Topical Acne Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Topical Acne Medication Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Topical Acne Medication Sales Value Share by Region (2021-2026) Table 31. Global Topical Acne Medication Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Topical Acne Medication Sales Value Share by Region (2027-2032) Table 33. Global Topical Acne Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Topical Acne Medication Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Topical Acne Medication Sales Value Market Share by Country (2021-2026) Table 36. Global Topical Acne Medication Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Topical Acne Medication Sales Value Market Share by Country (2027-2032) Table 38. Teva Company Information Table 39. Teva Business Overview Table 40. Teva Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Teva Topical Acne Medication Product Portfolio Table 42. Teva Recent Development Table 43. Mylan Company Information Table 44. Mylan Business Overview Table 45. Mylan Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Mylan Topical Acne Medication Product Portfolio Table 47. Mylan Recent Development Table 48. GlaxoSmithKline Company Information Table 49. GlaxoSmithKline Business Overview Table 50. GlaxoSmithKline Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. GlaxoSmithKline Topical Acne Medication Product Portfolio Table 52. GlaxoSmithKline Recent Development Table 53. Sun Pharma Company Information Table 54. Sun Pharma Business Overview Table 55. Sun Pharma Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sun Pharma Topical Acne Medication Product Portfolio Table 57. Sun Pharma Recent Development Table 58. Sine Pharma Company Information Table 59. Sine Pharma Business Overview Table 60. Sine Pharma Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Sine Pharma Topical Acne Medication Product Portfolio Table 62. Sine Pharma Recent Development Table 63. Mayne Pharma Company Information Table 64. Mayne Pharma Business Overview Table 65. Mayne Pharma Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Mayne Pharma Topical Acne Medication Product Portfolio Table 67. Mayne Pharma Recent Development Table 68. Lion Company Information Table 69. Lion Business Overview Table 70. Lion Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lion Topical Acne Medication Product Portfolio Table 72. Lion Recent Development Table 73. HUAPONT Company Information Table 74. HUAPONT Business Overview Table 75. HUAPONT Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. HUAPONT Topical Acne Medication Product Portfolio Table 77. HUAPONT Recent Development Table 78. Galderma Company Information Table 79. Galderma Business Overview Table 80. Galderma Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Galderma Topical Acne Medication Product Portfolio Table 82. Galderma Recent Development Table 83. Bausch Health Company Information Table 84. Bausch Health Business Overview Table 85. Bausch Health Topical Acne Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bausch Health Topical Acne Medication Product Portfolio Table 87. Bausch Health Recent Development Table 88. Almirall Company Information Table 89. Almirall Business Overview Table 90. Almirall Topical Acne Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Almirall Topical Acne Medication Product Portfolio Table 92. Almirall Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Topical Acne Medication Product Image Figure 2. Global Topical Acne Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Acne Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Acne Medication Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prescription Medicine Image Figure 8. Over-the-counter (OTC) Medicine Image Figure 9. Global Topical Acne Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Topical Acne Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Topical Acne Medication Sales Value Share by Type (2021-2032) Figure 12. Inflammatory Acne Image Figure 13. Non-inflammatory Acne Image Figure 14. Global Topical Acne Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Topical Acne Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Topical Acne Medication Sales Value Share by Application (2021-2032) Figure 17. Global Topical Acne Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Topical Acne Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Topical Acne Medication Sales Value (2021-2032) & (US$ Million) Figure 20. North America Topical Acne Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Topical Acne Medication Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Topical Acne Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Topical Acne Medication Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Topical Acne Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Topical Acne Medication Sales Value (2021-2032) & (US$ Million) Figure 26. South America Topical Acne Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Topical Acne Medication Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Topical Acne Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Topical Acne Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Topical Acne Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Topical Acne Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Medicine
  • Over-the-counter (OTC) Medicine
Applications
  • Inflammatory Acne
  • Non-inflammatory Acne
Companies covered
  • Teva
  • Mylan
  • GlaxoSmithKline
  • Sun Pharma
  • Sine Pharma
  • Mayne Pharma
  • Lion
  • HUAPONT
  • Galderma
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Topical Acne Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Topical Acne Medication Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Topical Acne Medication Market Dynamics
  1. 2.1 Topical Acne Medication Industry Trends
  2. 2.2 Topical Acne Medication Industry Drivers
  3. 2.3 Topical Acne Medication Industry Opportunities and Challenges
  4. 2.4 Topical Acne Medication Industry Restraints
3 Topical Acne Medication Market by Company
  1. 3.1 Global Topical Acne Medication Company Revenue Ranking in 2025
  2. 3.2 Global Topical Acne Medication Revenue by Company (2021-2026)
  3. 3.3 Global Topical Acne Medication Company Ranking (2024-2026)
  4. 3.4 Global Topical Acne Medication Company Manufacturing Base and Headquarters
  5. 3.5 Global Topical Acne Medication Company Product Type and Application
  6. 3.6 Global Topical Acne Medication Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Topical Acne Medication Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Topical Acne Medication Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Topical Acne Medication Market by Type
  1. 4.1 Topical Acne Medication Type Introduction
  2. 4.1.1 Prescription Medicine
  3. 4.1.2 Over-the-counter (OTC) Medicine
  4. 4.2 Global Topical Acne Medication Sales Value by Type
  5. 4.2.1 Global Topical Acne Medication Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Topical Acne Medication Sales Value by Type (2021-2032)
  7. 4.2.3 Global Topical Acne Medication Sales Value Share by Type (2021-2032)
5 Topical Acne Medication Market by Application
  1. 5.1 Topical Acne Medication Application Introduction
  2. 5.1.1 Inflammatory Acne
  3. 5.1.2 Non-inflammatory Acne
  4. 5.2 Global Topical Acne Medication Sales Value by Application
  5. 5.2.1 Global Topical Acne Medication Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Topical Acne Medication Sales Value by Application (2021-2032)
  7. 5.2.3 Global Topical Acne Medication Sales Value Share by Application (2021-2032)
6 Topical Acne Medication Regional Value Analysis
  1. 6.1 Global Topical Acne Medication Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Topical Acne Medication Sales Value by Region (2021-2032)
  3. 6.2.1 Global Topical Acne Medication Sales Value by Region: 2021-2026
  4. 6.2.2 Global Topical Acne Medication Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Topical Acne Medication Sales Value (2021-2032)
  7. 6.3.2 North America Topical Acne Medication Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Topical Acne Medication Sales Value (2021-2032)
  10. 6.4.2 Europe Topical Acne Medication Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Topical Acne Medication Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Topical Acne Medication Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Topical Acne Medication Sales Value (2021-2032)
  16. 6.6.2 South America Topical Acne Medication Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Topical Acne Medication Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Topical Acne Medication Sales Value Share by Country, 2025 VS 2032
7 Topical Acne Medication Country-level Value Analysis
  1. 7.1 Global Topical Acne Medication Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Topical Acne Medication Sales Value by Country (2021-2032)
  3. 7.2.1 Global Topical Acne Medication Sales Value by Country (2021-2026)
  4. 7.2.2 Global Topical Acne Medication Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Topical Acne Medication Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Topical Acne Medication Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Topical Acne Medication Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Topical Acne Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Topical Acne Medication Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Topical Acne Medication Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Topical Acne Medication Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Topical Acne Medication Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Topical Acne Medication Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Topical Acne Medication Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Topical Acne Medication Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Topical Acne Medication Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Topical Acne Medication Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Topical Acne Medication Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Topical Acne Medication Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Topical Acne Medication Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Topical Acne Medication Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Topical Acne Medication Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Topical Acne Medication Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Topical Acne Medication Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Topical Acne Medication Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Topical Acne Medication Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Topical Acne Medication Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Topical Acne Medication Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Topical Acne Medication Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Topical Acne Medication Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Topical Acne Medication Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Topical Acne Medication Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Topical Acne Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Topical Acne Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Topical Acne Medication Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Topical Acne Medication Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Topical Acne Medication Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Topical Acne Medication Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Topical Acne Medication Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Topical Acne Medication Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Sun Pharma
  20. 8.4.1 Sun Pharma Company Information
  21. 8.4.2 Sun Pharma Business Overview
  22. 8.4.3 Sun Pharma Topical Acne Medication Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharma Topical Acne Medication Product Portfolio
  24. 8.4.5 Sun Pharma Recent Developments
  25. 8.5 Sine Pharma
  26. 8.5.1 Sine Pharma Company Information
  27. 8.5.2 Sine Pharma Business Overview
  28. 8.5.3 Sine Pharma Topical Acne Medication Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sine Pharma Topical Acne Medication Product Portfolio
  30. 8.5.5 Sine Pharma Recent Developments
  31. 8.6 Mayne Pharma
  32. 8.6.1 Mayne Pharma Company Information
  33. 8.6.2 Mayne Pharma Business Overview
  34. 8.6.3 Mayne Pharma Topical Acne Medication Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mayne Pharma Topical Acne Medication Product Portfolio
  36. 8.6.5 Mayne Pharma Recent Developments
  37. 8.7 Lion
  38. 8.7.1 Lion Company Information
  39. 8.7.2 Lion Business Overview
  40. 8.7.3 Lion Topical Acne Medication Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lion Topical Acne Medication Product Portfolio
  42. 8.7.5 Lion Recent Developments
  43. 8.8 HUAPONT
  44. 8.8.1 HUAPONT Company Information
  45. 8.8.2 HUAPONT Business Overview
  46. 8.8.3 HUAPONT Topical Acne Medication Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HUAPONT Topical Acne Medication Product Portfolio
  48. 8.8.5 HUAPONT Recent Developments
  49. 8.9 Galderma
  50. 8.9.1 Galderma Company Information
  51. 8.9.2 Galderma Business Overview
  52. 8.9.3 Galderma Topical Acne Medication Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Galderma Topical Acne Medication Product Portfolio
  54. 8.9.5 Galderma Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Topical Acne Medication Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Topical Acne Medication Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
  61. 8.11 Almirall
  62. 8.11.1 Almirall Company Information
  63. 8.11.2 Almirall Business Overview
  64. 8.11.3 Almirall Topical Acne Medication Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Almirall Topical Acne Medication Product Portfolio
  66. 8.11.5 Almirall Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst